Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression.
Future Oncol
; 19(4): 279-287, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36916490
ABSTRACT
Aim:
The aim of this meta-regression was to assess the impact of mean/median age, mean/median tumor size, percentage of males in total sample, and total sample size on the comparative effectiveness of radiofrequency ablation (RFA) and stereotactic body radiation therapy (SBRT).Methods:
Ten studies reporting on the composite outcome of overall survival and local control were included.Results:
A significant relationship was found between age and overall survival at 1 and 2 for both RFA and SBRT. A significant relationship was noted also between age and local control at 1 and 2 years for RFA.Conclusion:
Patients treated with SBRT had a wider range of tumor sizes and larger tumor sizes; no relationship was observed between tumor size and overall survival or local control by SBRT.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Radiocirurgia
/
Carcinoma Hepatocelular
/
Ablação por Radiofrequência
/
Neoplasias Hepáticas
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article